Cited by 471Smoking Behavior and CessationGlobal Public Health Policies and EpidemiologySubstance Abuse Treatment and Outcomes

Effect of smokeless tobacco (snus) on smoking and public health in Sweden

Open access
Foulds, J, Ramstrom, L, Burke, M, Fagerström, K·2003·Tobacco Control

Abstract

OBJECTIVE: To review the evidence on the effects of moist smokeless tobacco (snus) on smoking and ill health in Sweden. METHOD: Narrative review of published papers and other data sources (for example, conference abstracts and internet based information) on snus use, use of other tobacco products, and changes in health status in Sweden. RESULTS: Snus is manufactured and stored in a manner that causes it to deliver lower concentrations of some harmful chemicals than other tobacco products, although it can deliver high doses of nicotine. It is dependence forming, but does not appear to cause cancer or respiratory diseases. It may cause a slight increase in cardiovascular risks and is likely to be harmful to the unborn fetus, although these risks are lower than those caused by smoking. There has been a larger drop in male daily smoking (from 40% in 1976 to 15% in 2002) than female daily smoking (34% in 1976 to 20% in 2002) in Sweden, with a substantial proportion (around 30%) of male ex-smokers using snus when quitting smoking. Over the same time period, rates of lung cancer and myocardial infarction have dropped significantly faster among Swedish men than women and remain at low levels as compared with other developed countries with a long history of tobacco use. CONCLUSIONS: Snus availability in Sweden appears to have contributed to the unusually low rates of smoking among Swedish men by helping them transfer to a notably less harmful form of nicotine dependence.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/tc.12.4.349

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Swedish snus differs from other types of snuff products as it contains lower levels of harmful substances.

    “Swedish snus differs from other types of snuff products as it contains lower levels of harmful substances [17], [18].”
  • Snus provides a unique opportunity to eliminate the effect of combustion and, to some extent, isolate the effect of nicotine on birthweight in an observational representative study.

    “However, snus provides a unique opportunity to eliminate the effect of combustion and, to some extent, isolate the effect of nicotine (with similar levels to those of smoked tobacco) on birthweight in an observational representative study.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Schildt E-B, Eriksson M, Hardell L, et al. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. J Cancer 1998;77:341-6.
  2. Lewin F, Norell SE, Johansson H, et al. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck. Cancer 1998;82:1367-74.
  3. Ye W, Ekstrom AM, Hansson LE, et al. Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer 1999;83:223-9.
  4. Lagergren J, Bergstrom, Lindgren A, et al. The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. J Cancer 2000;85:340-6.
  5. Bolinder G, de Faire U, Alfedsson L. Effects of long term smokeless tobacco use on metabolic cardiovascular risk factors and hemostatic function. MD thesis. Stockholm, 1997.
  6. Benowitz NL. Snuff, nicotine and cardiovascular disease: implications for tobacco control. J Am Coll Cardiol 1999;34:1791-3.
  7. Wicklin B. Differences in smoking habits and lung cancer incidence between Sweden and Norway. Poster presented at the 3 rd International Conference on Smokeless Tobacco. Stockholm, September 2002.
  8. Ramstrom L. Patterns of use of Swedish smoke-free tobacco, snus: A gate leading to smoking, or a way to give it up? Abstract from 4 th SRNT European Conference, Santandar, October 2002. Nicotine & Tobacco Research 2003;5:268.

Cited by

Sorted by citations

Authors
Foulds, J., Ramstrom, L., Burke, M., & Fagerström, K.
Affiliations
  • Rutgers, The State University of New Jersey (US)
  • University of Medicine and Dentistry of New Jersey (US)
Corresponding author
Foulds, J
Venue
Tobacco Control
Publisher
BMJ
Published
2003-12
Volume
12
Issue
4
Pages
349-359
ISSN
  • 0964-4563 (ISSN-L)
  • 1468-3318
OpenAlex
W2156436325
Cited by
471
References
61
Citations by year
2026: 9 · 2025: 10 · 2024: 11 · 2023: 15 · 2022: 16 · 2021: 8 · 2020: 16 · 2019: 22 · 2018: 19 · 2017: 20 · 2016: 25 · 2015: 28 · 2014: 26 · 2013: 28 · 2012: 26
FWCI
12.68
Type
journal article
Language
en
Open access
Locations
  • Tobacco Control (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • State of New Jersey Department of Health
  • Missouri Department of Health and Senior Services
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Keywords
snus, nicotine dependence, smoking cessation, tobacco harm, lung cancer, myocardial infarction, cardiovascular risk, fetal risk, sex differences in smoking
MeSH terms
Adult, Cardiovascular Diseases, Female, Humans, Male, Middle Aged, Neoplasms, Nicotine, Pregnancy, Pregnancy Complications, Risk Factors, Smoking, Sweden, Tobacco Use Disorder, Tobacco, Smokeless

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review